Sanofi India
Pharmaceutical Healthcare Portfolio
Sanofi India Ltd, listed on BSE, is the Indian subsidiary of Sanofi S.A., one of the world's leading multinational pharmaceutical companies founded in France. Sanofi's India portfolio spans diabetes, cardiovascular, rare diseases, vaccines and dermatology — with select products relevant to systemic conditions affecting hair and scalp health.
About Sanofi India Hair Care
Sanofi India Ltd (BSE listed) is the Indian arm of Sanofi S.A., a global biopharmaceutical company headquartered in Paris, France. Present in India since 1973 through predecessor companies, Sanofi India operates across diabetes, thrombosis, cardiovascular, rare diseases and dermatology. Its Dupixent (dupilumab) — a biologic for atopic dermatitis — represents the company's innovation in dermatology. While Sanofi does not have a consumer hair care line in India, its prescription dermatology and inflammatory disease portfolio may be relevant for patients with complex scalp conditions such as atopic dermatitis of the scalp, alopecia areata or autoimmune-related hair loss. All Rx products require specialist prescription. Hairsncares provides informational context and clinical referral support.
Is Sanofi India right for your hair loss?
Get a personalised clinical assessment from Dr. Amit — free, in 90 seconds.